Irving, TXNCT06504368Now EnrollingIRB Ready

Solid Tumors, Adult Clinical Trial in Irving, TX

Access cutting-edge solid tumors, adult treatment through this clinical trial at a research site in Irving. Study-provided care at no cost to qualified participants.

Sponsored by Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Quick Self-Assessment

See if you qualify for this Irving location

Preparing your pre-screening questions…

Expert Care in Irving

Access solid tumors, adult specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumors, adult treatment provided free

Apply for This Irving Location

Check if you qualify for this solid tumors, adult clinical trial in Irving, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Irving

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Irving site if eligible
  4. 4Begin participation

About This Solid Tumors, Adult Study in Irving

The study will evaluate the safety, tolerability, and pharmacokinetics of intravenous DCR-PDL1 in adults with solid tumors. Participants will be enrolled in one of 4 ascending-dose cohorts. Each treatment cycle will consist of multiple intravenous (IV) doses. Dose escalation decisions will be based on data collected during the dose-limiting toxicity (DLT) period.

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Who Can Participate

Inclusion Criteria

Male or female adults, aged greater than or equal to (≥) 18 years.
Participants are required to have a documented, locally advanced or metastatic solid tumor malignancy, or non-Hodgkin's lymphoma
that is refractory to standard therapy known to provide clinical benefit for their condition OR
have demonstrated evidence of disease progression or relapse, via imaging, during or following standard therapy known to provide clinical benefit for their condition, OR
have demonstrated intolerance to standard therapy known to provide clinical benefit for their condition. OR
for which no standard therapy is available
Measurable disease according to RECIST version 1.1.
Malignancy not currently amenable to surgical intervention.
ECOG performance status of 0, 1, or 2, and an anticipated life expectancy of ≥ 3 months at the time of signing the informed consent.
Other protocol defined inclusion criteria could apply

Exclusion Criteria

Participants with known CNS or leptomeningeal metastases not controlled by prior surgery or radiotherapy, or symptoms suggesting CNS involvement for which treatment is required.
Other protocol defined exclusion criteria could apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Irving?

Yes, this clinical trial (NCT06504368) has an active research site in Irving, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumors, Adult Treatment Options in Irving, TX

If you're searching for solid tumors, adult treatment options in Irving, TX, this clinical trial (NCT06504368) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Irving research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors, adult specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumors, adult clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Irving, TX

See all advanced solid tumors clinical trials recruiting in Irving — not just this study.

Browse Advanced Solid Tumors Trials in Irving →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Irving?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Irving, TX